The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

onconox.com

Stage

Other Investors | Alive

About OncoNOx

OncoNOx is a pharmaceutical company that focuses on the development of treatments which target disease-specific pathogenetic pathways. It is based in Copenhagen, Denmark.

OncoNOx Headquarter Location

Ole Maaløes Vej 3

Copenhagen,

Denmark

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

OncoNOx Patents

OncoNOx has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/7/2014

10/3/2017

Autoimmune diseases, Coagulopathies, Vascular diseases, Immunology, Rare diseases

Grant

Application Date

7/7/2014

Grant Date

10/3/2017

Title

Related Topics

Autoimmune diseases, Coagulopathies, Vascular diseases, Immunology, Rare diseases

Status

Grant

  • Where is OncoNOx's headquarters?

    OncoNOx's headquarters is located at Ole Maaløes Vej 3, Copenhagen.

  • What is OncoNOx's latest funding round?

    OncoNOx's latest funding round is Other Investors.

  • Who are the investors of OncoNOx?

    Investors of OncoNOx include SEED Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.